Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement

Dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) are severe disease manifestations that can occur following sequential infection with different dengue virus serotypes (DENV1-4). At present, there are no licensed therapies to treat DENV-induced disease. DHF and DSS are thought to be med...

Descripción completa

Detalles Bibliográficos
Autores principales: Fink, Ashley L., Williams, Katherine L., Harris, Eva, Alvine, Travis D., Henderson, Thomas, Schiltz, James, Nilles, Matthew L., Bradley, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517069/
https://www.ncbi.nlm.nih.gov/pubmed/28686617
http://dx.doi.org/10.1371/journal.pntd.0005721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517069/
https://www.ncbi.nlm.nih.gov/pubmed/28686617
http://dx.doi.org/10.1371/journal.pntd.0005721

Ejemplares similares